Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer

Tamoxifen is the standard endocrine therapy for breast cancers, which require metabolic activation by cytochrome P450 enzymes (CYP). However, the lower and variable concentrations of CYP activity at the tumor ...

from Most Recent Articles: Journal of Nanobiotechnology http://ift.tt/2Cyynpd
via IFTTT